RRX (NYSE: RRX) insider plans sale of 38,222 common shares
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
A Form 144 filing discloses a planned sale of 38,222 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of 8224828.00. The approximate sale date indicated is 02/09/2026.
The shares to be sold were originally acquired in multiple transactions, including merger-related issuances on several dates in 2021 and 2026, restricted stock vesting events from 2022 to 2023, stock appreciation rights, and option exercises granted in 2018 and 2021, some classified as compensation.
Positive
- None.
Negative
- None.
FAQ
What does the RRX Form 144 filing disclose?
The Form 144 filing discloses a planned sale of 38,222 common shares with an aggregate market value of 8224828.00. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 02/09/2026.
What does the Form 144 representation about material adverse information mean for RRX?
By signing the notice, the selling person represents they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 requirements intended to protect public investors from undisclosed negative information.
Does the RRX Form 144 mention prior sales in the last three months?
The document includes a section for securities sold during the past three months, but the excerpt provides no specific entries. The focus of the available information is the planned sale of 38,222 shares and the detailed acquisition history of the securities to be sold.